how safe is glp-1 Semaglutide for Weight Loss? GLP-1 Drug Savings: A Complete

In H1 2025, a weight loss app developer announced that they had partnered with a pharmaceutical company to personalize GLP-1 treatment using health data

The features they offer address real pain points that patients report, particularly around adherence and the cognitive burden of managing a complex titration schedule. However, none of these apps have been tested in randomized controlled trials, and the broader mHealth literature suggests that their benefits depend heavily on sustained engagement, she said

Preparation and therapeutic evaluation of engineered semaglutide and statin-lipid conjugate-based nanoparticle

Prior reports concluded small or no dementia risk difference between initiation of GLP1 receptor agonists versus SGLT2 inhibitors [16, 25, 26], consistent with our study

266,267 Despite the potential promise of GLP-1 RAs, a number of issues must be addressed if we are to maximize their long-term viability and impact

Another example is an extension of the STEP-1 trial, which randomised 1961 adults to either semaglutide or placebo for 68 weeks